NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Thanks for sharing meirluc but i do not agree.
30 or 31 placebo patients are alive 32.9 months from randomization. (36 months from surgery)
13 DCVax-l patients died between 32.9 and 36 months from randomization.(See NYAS data)
I have no idea how many placebo patients died between 32.9 and 36 months from randomization but I don't believe that 33 placebo patients are still alive 36 months from randomization.

88 or 89 patients are at risk 36 months from surgery. (32.9 months from randomization)=
58 (13 + 45) DCVax-L patients at risk 36 months from surgery.
30 or 31 placebo patients at risk 36 months from surgery. (I guess 1/3 from the non cross-over group. Look at the number of placebo patients at risk 24 months from randomization on the PFS KM curve = 13 patients )